Article
Glutathione S-transferase M1 polymorphism: a risk factor for hepatic venoocclusive disease in bone marrow transplantation.
Blood - 1 Sept 2004
Srivastava Alok, Poonkuzhali Balasubramanian, Shaji Ramachandran V, George Biju, Mathews Vikram, Chandy Mammen, Krishnamoorthy Rajagopal
Abstract excerpt
Hepatic venoocclusive disease (HVOD) in bone marrow transplantation (BMT) is attributed to toxicity of cytoreductive agents, especially busulfan and cyclophosphamide, in the conditioning therapy. Busulfan, as well as the metabolites of cyclophosphamide, are conjugated with glutathione (GSH), catalyzed by enzymes of the glutathione S-transferase (GST) family. To assess the impact of polymorphisms of the GST genes,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
